Lupin is recalling 1,11,648 units of Duloxetine delayed-release capsules USP, in the strength of 30 mg, on account of failed dissolution specification. The ongoing voluntary nationwide recall is a class III recall, it said. Zydus Pharmaceuticals USA Inc, a unit of Cadila Healthcare, is also recalling 19,812 bottles of Paroxetine tablets in the strength of 30 mg from the US market. The reason for the ongoing voluntary nationwide recall is “presence of foreign tablets/capsules: Risperidone tablets were found in bottle of Paroxetine tablets”, the report stated. The product was manufactured by Cadila Healthcare and the recall is a class II recall, the regulator added.